HUMAN HEPATIC STELLATE CELLS (hHSC) are liver-specific multifunctional mesenchymal cells known to play a key role in human liver physiology as well as in the fibrogenic progression of chronic liver diseases (13) . Following acute or chronic liver tissue damage, hHSC undergo a process of activation and phenotypical modulation into myofibroblast-like cells. Chronic activation of hHSC is a key event in the hepatic fibrogenic process and is characterized by an array of key biological changes, including cell proliferation, motility, and contraction, processes which are tightly dependent on a dynamic and extensive reorganization of the actin cytoskeleton (12, 34) . This process requires a specific conformation of actin, i.e., monomeric, oligomeric, or polymeric actin, that needs to be associated with actin binding-and actin filament-binding proteins to form complexes in a reversible and regulated manner (11) . Knowledge of the localization and function of actin filament-binding proteins in hHSC is still very scarce. The key role of the actin filament-binding protein myristoylated alanine-rich kinase C substrate (MARCKS) in the modulation of platelet-derived growth factor (PDGF)-induced hHSC motility has been previously characterized by our group (33) . In particular, MARCKS and the PDGF␤-receptor are functionally associated and the activation of PKC⑀ is indispensable for PDGF-BBinduced MARCKS phosphorylation and cell migration (33) . In addition, we have also shown, by employing serial analysis of gene expression (SAGE) analysis, that the process of hHSC activation is characterized by a marked upregulation of MARCKS mRNA (GEO datasets GSE5022, www.ncbi.nlm.nih.gov) (5) . The established function of MARCKS is the reorganization of the local actin cytoskeleton by a process of phosphorylation and dephosphorylation. This is achieved through the so-called "electrostatic switch mechanism" of MARCKS which involves a phosphorylation site domain (PSD) containing an actin-binding sequence (hexapeptide FSFKKS) (15, 44) . This binding site interacts also with protein kinase C (PKC), calmodulin, and phophatidylserine, and it sequesters phosphatidylinositol 4,5-bisphosphate (PIP 2 ) (39, 43) . Overall, MARCKS PSD allows the selective targeting and regulation of numerous signal transduction complexes (21, 24 ) that result in a local transient softening and remodeling of the actin cytoskeleton (1, 2) .
During mitosis, assembly and disassembly of actin polymers is crucial to determine cell shape and polarity. In this context, actin reorganization needs to be tightly coordinated to allow the cell to enter proper cell cycle (41) and this is achieved by the interaction between the cortical actin cytoskeleton and specific actin-binding proteins (3, 6) . However, the mechanisms by which monomeric actin and actin filaments, in combination with actin-binding proteins, modulate cell shape and mechanical properties during mitosis in hHSC, as well as in other cell types, remain to be elucidated.
Therefore, the aim of this study was to investigate the possible existence and functional role of MARCKS as an actin-binding and actin filament cross-linking protein during mitosis in hHSC. By employing different approaches we demonstrate that MARCKS protein expression regulates the reorganization of the actin cytoskeleton necessary to induce mitosis in this key fibrogenic cell type.
MATERIALS AND METHODS

Reagents
Antibodies against ␣-smooth muscle actin (␣-SMA) (mouse ascites, clone 1A4), ␤-actin (AC-15), and anti-actin (rabbit, 20 -33), 4=,6-diamidino-2-phenylindole (DAPI), phalloidin tetramethylrhodamine isothiocyanate (TRITC) and all reagents used in this study are from Sigma Aldrich unless otherwise mentioned. Antibodies against Aurora B kinase (AIM-1) were purchased from Sigma (rabbit, A5102) or BD Transduction (mouse, AIM-1). Primary antibodies against MARCKS (N-19 and M20), phosphorylated (P)-MARCKS (Ser159/ 163), ␣-tubulin (H-300), and ␥-tubulin (H-183) were purchased from Santa Cruz Biotechnology, as well as their secondary antibodies, respectively, horseradish peroxidase-conjugated goat or rabbit IgG. Fluorescent conjugated secondary antibodies Alexa Fluor 488 rabbit anti-goat IgG, Alexa Fluor 488 goat anti-rabbit IgG, Alexa Fluor 546 rabbit anti-mouse IgG, and Prolong Gold antifade reagent were purchased from Molecular Probes. CyTM5-conjugated AffiniPure bovine anti-goat IgG was purchased from Jackson ImmunoResearch. All antibodies were used according to the manufacturer's manual.
Cells and Cell Culture
hHSC were isolated from wedge sections of normal human liver unsuitable for transplantation, as extensively described elsewhere (29) . Cells were cultured in Iscove's modified Dulbecco's medium supplemented with 0.6 U/ml insulin, 2 mM/l glutamine, 0.1 mM/l nonessential amino acids, 1.0 mM/l sodium pyruvate, antibioticantifungal solution, and 20% fetal bovine serum (FBS) (all provided by GIBCO). Experiments described in this study were performed on cells between passage 3 and 5 by employing at least three independent cell preparations. At these stages of culture, these primary cells show functional and ultrastructural features of fully activated HSC with a cell marker profile identical and well characterized to the so-called "interface" myofibroblasts detected in liver tissue specimens at the border between "active" fibrotic septa and the parenchyma of liver lobule (9) .
Immunohistochemistry
These experiments were conducted on frozen sections as described in detail elsewhere (23, 26) . Dried sections were incubated with a primary specific antibody against MARCKS (kindly gifted by Prof. P. Caroni, Friedrich Miescher Institute, Basel, Switzerland) (21) and after washing, incubated with affinity-purified mouse anti-rabbit antibodies. At the end of the incubation, sections were washed twice in Tris-buffered saline, then incubated with alkaline phosphate antialkaline phosphatase complex and developed. Control sections were treated with omission of the primary antibody or specimens were incubated with an isotype-matched control antibody under identical conditions.
Protein Extraction and Western Blot Analysis
Total protein extraction and Western blot analysis. Cells were lysed in RIPA buffer containing 20 mM/l Tris·HCl, pH 7.4, 150 mM/l NaCl, 5 mM/l EDTA, 1% Nonidet P-40, 1 mM/l Na 3VO4, 1 mM/l PMSF, 1:100 cocktail inhibitor, and 0.05% aprotinin (wt/vol). Insoluble proteins were discarded by centrifugation at 10.000 rpm at 4°C, and total proteins were measured (Pierce, Rockford, IL) and stored at Ϫ80°C for further analysis. For demonstrating equal loading between the samples during Western blot analysis, an antibody against ␣-SMA, total actin, or ␣-tubulin was used (33) .
Total protein extraction of mitotic cells (shake-off method). An easy to handle and classical standard method was used to separate and harvest mitotic cells from interphase cells in an asynchronous culture, i.e., shake-off method. Loosely attached, the mitotic cells were shaken off the culture flask, collected, and centrifuged. Cell lysis buffer was added to the pellet, and total protein amount was measured as mentioned before.
Chromosome-enriched fractionation. Briefly, after trypsinization of the cells, cell suspension was washed in 1ϫ PBS and centrifuged twice to remove culture medium and trypsin. Cells were lysed on ice for 30 min by Dounce homogenization in a buffer consisting of 10 mM HEPES (pH 7.9), 10 mM KCl, 1.5 mM MgCl 2, 0.34 M sucrose, 10% glycerol, 1 mM dithiothreitol, 0.25% Triton X-100, and a protease inhibitor cocktail inhibitor (18) . Thereafter, chromosomeenriched fractions were collected by low-speed centrifugation at 1,300 g for 5 min and were washed twice in the same buffer. Chromosomeenriched cytoplasmic fractions were prepared from the supernatant by further centrifugation at 16,000 g for 20 min, and total protein amount was measured as mentioned before.
RNA Interference
Transient gene silencing in hHSC was performed by using human MARCKS validated SMARTpool small interfering (si)RNA (M-004772-00), and human Aurora B kinase (AUBK) (AIM-1) validated SMARTpool siRNA (M-003326-02) and the nonspecific, scrambled control siRNA (Custom SMARTpool siRNA Design Service of Dharmacon, Lafayette, CO). For transfection, siLentFect Lipid Reagent (Bio-Rad) was employed. Briefly, 200,000 cells were cultured per 6-well plate in complete medium. After 24 h, 30 nM AUBK siRNA or 50 nM MARCKS SiRNA was mixed with 5 l of siLentFect Lipid Reagent and added to the cell culture. A scrambled siRNA was used for control cells, and 1 g of pmaxGFP vector (Dharmacon) was used to evaluate the transfection efficiency microscopically.
Cell Cycle Analysis
Single-cell suspensions were washed in cold PBS containing 0.1% sodium azide; 1 ϫ 10 6 cells were then fixed in 2% formaldehyde. Fixed cells were resuspended in 1 ml of distilled water containing 10 mM HEPES, 140 mM NaCl, 2 mM CaCl 2, pH 7.4, in the presence of 3 M DAPI. Cells were incubated with DAPI for 15 min at room temperature in the dark. After staining, a total of at least 10,000 cells/samples were acquired by using a BDLSR II flow cytometer (BD Biosciences). Cell cycle analysis was performed using Flowjo software (Tree Star, Ashland, Oregon).
Immunofluorescence Staining and Microscopy
Cells were fixed in 4% paraformaldehyde for 10 min and permeabilized with 0.2% Triton X-100, followed by dehydration in absolute acetone for 5 min at Ϫ20°C. Coverslips were blocked for 1 h with 3% bovine serum albumin ϩ 0.05% Igepal/1ϫ PBS, followed by several washing steps. Cells were incubated for 1 h with the specific first antibody raised against the protein of interest and then blocked with the specific conjugated secondary antibody. Finally, coverslips were washed and then mounted with Prolong Gold-antifade reagent. In all immunofluorescence experiments, the specificity of the antibodies used was evaluated by performing the staining solely with the secondary antibody.
Immunofluorescence microscopy. Samples were imaged using a Leica DM6000B microscope equipped with a z-axe motorized stage and a ϫ100 1.3 numerical aperture (NA) oil immersion objective. Images were acquired with a Leica DFC350FX digital camera as z-stack series.
Fluorescence microscopy. Fluorescence intensity of phalloidin TRITC-stained cells was measured in images acquired using a ϫ20 0.5 NA objective in the same imaging session under identical illumination and acquisition settings. Fluorescence intensity measurements were done with ImageJ software (National Institutes of Health, Bethesda, MD) using one protocol, i.e., the integrated intensity above threshold of phalloidin TRITC in one channel was computed and normalized by the number of nuclei (DAPI staining) measured in the other channel, thus giving an average staining intensity per cell. Total measured cells were 232 for control cells and 244 for MARCKS-silenced cells.
Confocal imaging. Samples were acquired using a Leica SP2-AOBS confocal microscope through a ϫ63 1.4 NA oil-immersion objective.
Video time lapse imaging. To determine the impact of MARCKS expression on the cell cycle, time lapse microscopy was employed that enabled tracking of the cell cycle progression at the single cell level for 24 h. Video microscopy was performed by culturing cells in a microincubator (Pecon) with controlled humidity, temperature, and CO 2, mounted on inverted Leica AM6000 microscope with fully motorized stage. Experiments were performed acquiring multiple fields of view for each experimental condition by using oblique illumination and a ϫ20 air objective. Multifield acquisition was done using Leica LasAF software.
All images were deconvoluted using Huygens Professional software and mounted for final display with ImageJ or Adobe Photoshop. Images are presented as maximum intensity projections along the z-axis.
Duration time of mitosis. Mitotic entry was scored by the first image showing extensive cell rounding and is defined as the start time, whereas mitotic exit was scored as the last image showing the pinching-off of the two daughter cells (stop) (8, 19, 45) . The duration time of mitosis (DTM) was measured for each mitotic cell in both conditions, thus the total sum of the DTM and the average DTM were calculated (error bars represent standard error; P Ͻ 0.005, Student's t-test). The obtained average DTM of scrambled control cells (marked as t in Fig. 6 ) was used as a cutoff and was compared with the DTM in MARCKS-depleted cells (marked as Ͼt).
Statistical Analysis
Statistical differences between groups were determined by unpaired Student's t-test. Two groups were considered different when P Ͻ 0.05 or 0.005, as mentioned in the figure legends.
RESULTS
MARCKS Distribution In Human Liver and During Mitosis in hHSC
MARCKS expression was investigated in human liver by staining with a specific antibody against MARCKS. As illustrated in Fig. 1A , MARCKS expression was not detectable in normal human liver whereas it was clearly evident in cirrhotic liver at the sinusoidal level. This in agreement with the observation that upregulation of MARCKS mRNA is a feature of hHSC activation (5).
Confocal microscopy was employed to determine possible subcellular localizations of MARCKS and P-MARCKS during cell division in hHSC. Immunofluorescence was performed to detect MARCKS or P-MARCKS in conjunction with AUBK, a chromosomal marker (4, 35) . During early pro-metaphase, AUBK was localized at the chromosomal level in correspondence with the perichromosomal layer (28, 42) and at the metaphase plate. As expected, during late telophase, AUBK moved towards the midbody where the cleavage furrow will be subsequently formed (7) (Fig. 1, B and C) .
MARCKS was shown to be very homogeneously distributed throughout all mitotic steps (Fig. 1B) whereas P-MARCKS displayed distinct phase-dependent localizations (Fig. 1C) . During early pro-metaphase, P-MARCKS was detectable on the inner side of the AUBK containing perichromosomal layer (Fig. 1C) . During metaphase, P-MARCKS was detectable as two punctuate structures at the centrosomal level (Fig. 1C) , and cytokinesis was characterized by a strong accumulation of AUBK (Fig. 1, B and C) and P-MARCKS (Fig. 1C and inset) .
These data suggest, for the first time, that P-MARCKS is associated with the formation of the cleavage furrow during cytokinesis in hHSC. Because of the distinct mitotic phasedependent localizations of P-MARCKS, mitotic cells were separated from interphase cells by employing the well-established shake-off method. Western blot analysis in these cell preparations showed that MARCKS becomes highly phosphorylated during mitosis in hHSC (Fig. 1D) .
Since P-MARCKS was observed in close proximity to chromosomes during chromosomal condensation, the possibility that P-MARCKS belongs to the group of chromosomal-associated proteins was investigated (14) . Accordingly, a chromosome fractionation analysis was performed in mitotic hHSC (18) . Aurora B kinase, previously detected at the chromosomal level, was present in the enriched chromosome fraction that contains, besides chromosomes, also chromosome-associated proteins, whereas P-MARCKS was detectable only in the chromosomal cytosolic fraction of mitotic cells, indicating that MARCKS is not directly associated with the chromosomes. ␣-Tubulin and actin, used as controls, were present in both fractions (18) (Fig. 1E) .
Phosphorylated MARCKS Is a New Centrosome Protein in hHSC
Phosphorylated MARCKS has been previously described as a new centrosome component, colocalizing with pericentrin and ␥-tubulin during meiosis in mice oocytes (25) . Because of the strong accumulation of P-MARCKS inside the perichromosomal layer (see Fig. 1C ), we further investigated whether P-MARCKS acts as a centrosome protein in hHSC during the very early mitotic steps. As shown in Fig. 2A , confocal microscopy analysis shows that, already during early pro-metaphase, P-MARCKS was detectable as two punctuate dots surrounded by very diffusely spread chromosomes identified by the presence of AUBK staining. Next, during pro-metaphase, P-MARCKS was observed as two punctuate structures within the typical perichromosomal layer marked by AUBK. Finally, during metaphase, P-MARCKS-containing dots were localized in the area of condensed chromosomes identified by AUBK staining (Fig. 2A) .
Pro-metaphase is known to be an actin-and microtubuledependent process, and the chemical inhibition of actin polymerization results in complete failure of chromosomal congression (22) . Knowing that the phosphorylation of MARCKS prevents the actin cross-linking activity of MARCKS (15), we investigated whether the distribution of actin would be affected by the distinct phase-dependent localizations of P-MARCKS. As illustrated in Fig. 2B , the ␤-actin-containing filaments, abundantly present in hHSC, were absent in the area surrounding the P-MARCKScontaining dots during pro-metaphase, confirming that the electrostatic switch mechanism of MARCKS is fully operative also during mitosis. Altogether, these observations suggest that P-MARCKS acts as a centrosome protein and further substantiate the role of actin during mitosis.
RNAi Against MARCKS Inhibits hHSC Proliferation by Interfering With Cytoskeleton Reorganization
To further strengthen our hypothesis that MARCKS plays a key role during mitosis in hHSC, we employed RNA interference (RNAi) against MARCKS. SiRNA treatment resulted in a drastic reduction in MARCKS protein expression after 72 h A: representative photomicrographs of MARCKS immunostaining (red color) in specimens from patients with normal liver and chronic liver injury. Intrahepatic immunostaining for MARCKS was found to be increased at the hepatic sinusoidal level during chronic liver injury but not in normal liver. B and C: cells were immunostained against MARCKS or phosphorylated (P)-MARCKS in combination with Aurora B kinase (AUBK). Confocal images were taken of cells in different phases of the cell cycle. Micrographs are projected as two-color merged images in which MARCKS and P-MARCKS fluorescence is in green and AUBK is shown in red (ϫ63 magnification) (n ϭ 3). Representative picture of P-MARCKS and AUBK shows the presence of both proteins at the cleavage furrow (scale bar 2 m) (n ϭ 3). D: MARCKS and P-MARCKS protein expression was compared between total cell lysates of mitotic cells (MC) vs. interphase cells (IC). Western blot analysis shows that MARCKS is highly phosphorylated in mitotic cells in comparison to interphase cells (n ϭ 3). E: chromosomal fractionation analysis of mitotic cells shows the presence of AUBK in the chromosomal fraction (MC chrom.), whereas P-MARCKS is a non-chromosomalassociated protein (MC chrom. cyto) (n ϭ 2). from transfection. In parallel, FACS analysis was performed to assess the cell cycle profile of siRNA-treated cells compared with scrambled control cells. The cell cycle profile of hHSC siRNA treated against MARCKS was characterized by G1 phase inhibition which coincided with a tendency to increase in S phase and G2 phase (Fig. 3A) .
Because of the dynamic relocalization of MARCKS during mitosis in hHSC and its effect on cell cycle, we investigated whether the observed inhibitory effect of MARCKS is due to its actin monomeric and filament-binding capacities. Therefore, cells were siRNA treated against MARCKS and the possible redistribution of actin filaments and ␤-actin was investigated. MARCKS siRNA treatment was followed by a phalloidin-TRITC actin filament staining. When analyzing the F-actin distribution in MARCKS-depleted cells, these cells showed a significant decrease in both cytosolic and cortical F-actin when compared with control cells (Fig. 3B) . Indeed, measurement of phalloidin-TRITC staining intensity between scrambled control cells and MARCKS-depleted cells revealed that the phalloidin-TRITC staining intensity was significantly higher in control cells when compared with MARCKS-depleted hHSC (Fig. 3B) .
Confocal microscopy was employed to compare the localization of ␤-actin, an important actin isoform in hHSC, between control cells and MARCKS-depleted cells. As shown in Fig. 3C , in scrambled control cells, ␤-actin accumulated at the plasma membrane. In contrast and owing to the absence of MARCKS in siRNA-treated cells, the distribution of ␤-actin was characterized by a strong homogeneous cytosolic staining with a complete loss of the ␤-actin cortical staining (Fig. 3C ). This resulted in MARCKS-depleted cells showing an abnormal metaphase and telophase formation (Fig. 3C) . These data indicate that MARCKS, an actin filament-binding protein, regulates the rate of actin filament polymerization according to the "electrostatic switch model" and that the ␤-actin localization during mitosis is affected by MARCKS-depletion.
RNAi Against Aurora B Kinase is Characterized by Binucleation and Inhibition of Cell Cycle in hHSC
Protein downregulation of AUBK, or inhibition of the kinase activity, has been shown to result in an inability to complete cell division, thus leading to multinucleated cells as is often observed in neoplastic cell lines (4, 7, 20) . In this set of Fig. 2 . Phosphorylated MARCKS is a new centrosome protein in hHSC. Cells were immunostained against P-MARCKS in combination with AUBK or ␤-actin. Confocal microscopic images were taken of cells in early pro-metaphase and pro-metaphase. A: phosphorylated MARCKS was detectable as two punctuate dots during early pro-metaphase and metaphase, whereas during pro-metaphase P-MARCKS was observed within the perichromosomal layer stained by AUBK (scale bars 5 m). B: phosphorylated MARCKS was detectable as two punctuate dots during pro-metaphase. This zone was free from ␤-actin-containing actin filaments, indicating that the "electrostatic switch mechanism" of MARCKS is still fully operative. Micrographs are projected as two-color merged images in which P-MARCKS fluorescence is in green and AUBK or ␤-actin is shown in red (ϫ63 magnification, scale bars 2 m and 4 m) (n ϭ 3). Fig. 3 . Silencing MARCKS in hHSC leads to a G2 block by inducing aberrant actin filament formation and ␤-actin delocalization in hHSC. A: cells were silenced against MARCKS for 72 h followed by Western blot analysis to show transfection efficiency, and in parallel FACS analysis was performed. siRNA against MARCKS inhibited G1 phase and induced a tendency to increase in S/G2 phase (n ϭ 2). B: actin filaments were visualized by phalloidin tetramethylrhodamine isothiocyanate (TRITC), and phalloidin TRITC staining intensity was measured in MARCKS-depleted vs. scrambled control cells. MARCKS-depleted cells contain much less cytosolic F-actin in contrast to the scrambled control cells, which was confirmed by a 75% reduction in phalloidin TRITC staining intensity. Error bars represent SE. *P Ͻ 0.005 (Student's t-test). Total measured cells were 232 for scrambled control cells and 244 for MARCKS-depleted cells. Phalloidin staining was grayscaled by Adobe Photoshop (ϫ20 magnification). False colored images by Gradient LUT show the intensity of F-actin (scale bars 5 m). C: RNA interference (RNAi) against MARCKS was performed and hHSC were immunostained against P-MARCKS and ␤-actin. Confocal analysis demonstrated that, in scrambled control cells, ␤-actin was detectable at the cell cortex and P-MARCKS was homogenously expressed during metaphase, with accumulation at the cleavage furrow. Actin patches are formed by ␤-actin during cytokinesis which embedded the previously detected ringlike structure containing P-MARCKS. Micrographs are projected as two-color merged images in which P-MARCKS fluorescence is in green and ␤-actin is shown in red (ϫ63 magnification, scale bar 1 m). MARCKS-depleted cells showed a very weak diffuse staining of P-MARCKS, whereas the strong cortical ␤-actin staining observed previously in control cells was absent, indicating a shift in ␤-actin localization (ϫ63 magnification) (n ϭ 3). DAPI, 4=,6-diamidino-2-phenylindole. experiments we employed RNAi against AUBK in primary hHSC. SiRNA treatment against AUBK resulted in a drastic reduction of protein expression for AUBK after 72 h from transfection (Fig. 4A) . In parallel, FACS analysis was performed to assess the cell cycle profile of siRNA-AUBK-treated cells compared with scrambled control cells (Fig. 4B) . Aurora B kinase-depleted cells showed an inhibition in both G1 phase and S phase with a significant increase in G2 phase. As shown by classical DNA staining, AUBK-depleted cells clearly showed the presence of two nuclei per cell in contrast with the typical mononuclear cells observed in scrambled control hHSC, or siRNA-treated hHSC against MARCKS (Fig. 4C) . These data suggest that hHSC with a reduced AUBK protein expression level were able to divide their nuclear content, as shown by FACS analysis, but are impaired in cytokinesis that caused the generation of multinucleated hHSC.
Depletion of MARCKS Causes AUBK Delocalization and Spindle Abnormalities During Mitosis in hHSC
RNAi against MARCKS was performed to further investigate whether MARCKS-depletion affects other key mitotic regulators such as AUBK, and specifically their localization during the different steps in mitosis. Confocal analysis demonstrated that the most common observed mitotic phenotype featured an unusual metaphase or telophase. Phosphorylated MARCKS, which was previously detected as a centrosome protein in scrambled control cells, was delocalized in MARCKS-depleted cells and this coincided with a very homogeneous staining of AUBK, or the absence of AUBK in the metaphase plate (Fig. 5A) . The same pattern was observed, with a few exceptions, during telophase, in which AUBK was detectable at the midbody, but with an aberrant positioning of P-MARCKS towards the metaphase plate and the chromosomes (Fig. 5A) . As previously observed in metaphase, the absence of P-MARCKS coincided with loss of AUBK during telophase (see also Fig. 1C ). In addition, decondensation and misorientation of chromosomes was observed in MARCKSdepleted cells when nuclei were counterstained with DAPI.
To investigate the effects of MARCKS-depletion on possible spindle abnormalities, an antibody against ␥-tubulin was employed. In MARCKS RNAi-transfected cells, ␥-tubulin was detectable as a very diffuse staining associated with punctuate structures delocalized or absent when compared with scrambled control cells (Fig. 5B) . Overall, the delocalization or absence of ␥-tubulin in MARCKS-depleted cells paralleled with the staining pattern of P-MARCKS (Fig. 5A) .
Overall, these data indicate that MARCKS-depletion by transient RNAi induces an aberrant localization of AUBK and ␥-tubulin and that, during mitosis in primary hHSC, the actin cytoskeleton, mitotic regulators, and microtubule network are finetuned and must be coordinated to obtain a correct cellular division.
MARCKS-Depletion Delays Duration Time of Mitosis in hHSC
The possibility that the observed lack of actin filament assembly and displacement of ␤-actin, ␥-tubulin, and AUBK in MARCKS-depleted cells could dynamically impact on the mitotic process was then investigated. To this aim, the different phases of cell division of siRNA MARCKS-treated cells were monitored by oblique-illumination video time lapse-imaging and compared with scrambled control cells. More specifically, the DTM of each mitotic cell was measured. Scrambled control cells showed an average DTM of 80 min (Fig. 6, A and B, and Supplemental Video S6.1; Supplemental Material for this article is available online at the Journal website). The results of these experiments revealed that mitotic hHSC exposed to MARCKS siRNA are characterized by a significant increase in DTM when compared with scrambled control cells (Fig. 6B) . Indeed, Ͼ22.2% of this cell population was characterized by a significant increase in DTM when compared with control cells. In the majority of MARCKS-depleted cells, random contraction of the plasma membrane was frequently observed and characterized by a defect in fully rounding up with part of the membrane remaining extended when compared with the scrambled control cells. This feature coincided with a delay in cleavage furrow ingression and pinching-off of the two daughter cells (Fig. 6 , C and E, and Supplemental Videos S6.2 and S6.3). This a typical phenomenon observed in mitotic cells when the actin cytoskeleton is hampered during mitosis (Fig. 6 , C and E).
DISCUSSION
The knowledge on the biology of hHSC has grown exponentially in the past two decades. The transdifferentiation process of quiescent hHSC into activated myofibroblasts is a key event in liver injury and is characterized by an array of key biological changes that results in increased cell proliferation, motility, and contraction that goes along with morphological changes and the formation of actin stress fibers and actin filaments which define the structural and mechanical backbone of activated hHSC (13, 17) .
To date, experimental evidence linking the relationship between cytoskeletal changes and the proliferative attitude of this key profibrogenic cell type is still very scarce. Our study demonstrates that, besides the well-established increase in actin cytoskeleton components, the process of HSC activation is characterized by an upregulation of actin filament-binding proteins such as MARCKS that is indispensable to ensure an adequate mechanical force necessary for mitosis and, ultimately, for cell proliferation.
The localization of MARCKS and its target actin was analyzed during different phases of the mitotic cycle. During this process, MARCKS-depletion substantially inhibits actin filament formation and reduces cell cycle progression through a delay in the duration time of mitosis. In particular, this study provides for the first time evidence that MARCKS exhibits a tightly regulated pattern of localization during different phases of the cell cycle in primary, nontransformed cells such as hHSC. From a general point of view, the results of this analysis highlight a more complex and articulated role of MARCKS, an important PKC substrate, compared with current interpretations based on scarcely documented cell cycle-dependent protein expression of MARCKS in neoplastic cells (16, 30) . This is the first study that demonstrates the role of MARCKS in primary cells and this was obtained by employing methodologies able to investigate the key events of the cell cycle in a dynamic fashion, thus overcoming the limitations of standard static biochemical methods. To provide a more extensive analysis of the role of MARCKS in the cell cycle, a possible interaction between MARCKS and AUBK, an important key mitotic checkpoint, was evaluated in hHSC. The specific cellular distribution of AUBK was shown during the cell cycle in hHSC, and depletion of AUBK resulted in cell cycle inhibition and the formation of binucleated hHSC cells. This is in agreement with a recent study performed on neoplastic cells and primary cell lines that demonstrated a key role for AUBK in abscission timing that prevents tetraploidization by furrow regression in response to chromosome segregation defects (38) . In addition, MARCKS-depletion affects several important mitotic phases as was demonstrated by the development of different phenotypes during metaphase and telophase with loss of AUBK or AUBK metaphase displacement. Importantly, these results clearly demonstrate that AUBK cellular distribution during the different mitotic steps depends on the presence of MARCKS and actin, and they further confirm that mitosis is a process characterized by a dynamic fine-tuned reorganization of the actin cytoskeleton with a close partnership between actin filaments, microtubules, and mitotic regulators (32, 40) . The accumulation of ␤-actin, AUBK, and P-MARCKS at the cleavage furrow formation suggests a new role for MARCKS as a component of the actin-myosin contractile ring. This structure is a site where both de novo assembly of actin occurs and preexisting actin filaments and myosin-II are recruited to form a contractile ring which is characterized by a high dynamic actin turnover (12, 27) . Hence, MARCKS through the regulation of the rate of actin polymerization or depolymerization, and AUBK, determining the abscission timing, function in a coordinated mechanism influencing the rate of cleavage furrow contraction and abscission timing (1, 21, 36, 38) . The results obtained by employing RNAi and live cell imaging indicate that MARCKS negatively affects the generation of the mechanical force necessary to pinch-off the two daughter cells, which results in lengthening of the cell cycle time, indicating that MARCKS, an actin filament-binding protein and major protein kinase C substrate, is key to proper cell cycle and that interfering with its actin-binding activity or phosphorylation status inhibits cell cycle. Recently, investigations are focused on exploring actin and the actin-binding proteins as possible targets for treatment. For example, biochemical inhibition of fascin, which has an identical actin-binding domain, as was previously identified in MARCKS, inhibits mammary tumor metastasis (10, 37) . Actin is the cellular receptor of Bistramide A, a new antiproliferative compound that inhibits cancer progression in vitro and in vivo (31) .
In conclusion, the data presented herein indicate that actin and its anchor protein MARCKS are dynamically involved in the mitotic process and that these proteins must be in the appropriate position, at the right time, and in the correct amount. This is in agreement with the idea that besides the well-known microtubule system, actin-binding proteins and an actin meshwork need to be present to guide the chromosomes through mitosis and to finalize the process of cytokinesis in hHSC. Altogether, these observations provide a relevant advancement in the biology of activated hHSC, i.e., the relationship between the increased proliferative attitude and cytoskeletal changes, and in the understanding of their key profibrogenic role.
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